CIK 0001368514 · Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562590442
- Phone
- (201) 478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Shares withheld for taxes EVP, CFO gave up 15,268 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market buy Director bought 130,000 shares at $3.71 ($482,144)
- 4 Open-market buy Director bought 25,000 shares at $3.90 ($97,500)
- 4 Open-market sale Director sold 1,433,304 shares at $3.87 ($5,544,737)
- 144 Insider Sale of Securities
- 4 Open-market sale President and CEO sold 250,000 shares at $4.15 ($1,038,350)
- 144/A Insider Sale of Securities
- 4 Open-market sale President and CEO sold 510,472 shares at an average $4.54 ($2,318,972)
- 4 Open-market sale EVP, CFO sold 389,762 shares at an average $4.53 ($1,766,130)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Shares withheld for taxes EVP, CFO gave up 15,268 shares (to pay taxes)
- 4 Shares withheld for taxes President and CEO gave up 20,051 shares (to pay taxes)
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
Page 12 of 50 · 1,000 filings